This activity will highlight the growing challenges in HTx and explain the current HTx allocation policy, review ways to provide a more equitable distribution of organs to expand the donor pool, and discuss methods to improve quality of life and survival for HTx recipients.

This activity will identify predictive factors for these outcomes that may allow for earlier transplantation.

This activity will focus on the integration of behavioral health services into the clinical primary care setting for SUD and discuss breaking the stigma and setting the stage for collaboration. Healthcare Effectiveness Data and Information Set (HEDIS) measures related to SUD will also be examined, as well as why these measures are important to establish a therapeutic alliance and a collaborative, stigma-free approach to care.

This activity will explore recent advances in the diagnosis and treatment of leukodystrophies, including current clinical trials. It will also share insights and perspectives from individuals and their family/caregiver(s) and provide strategies to support their well-being.